Article Menu
- Academic Editor
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Vives, S.
- Quintela, D.
- Morgades, M.
- Cano-Ferri, I.
- Serrano, A.
- Acuña-Cruz, E.
- Cervera, M.
- Díaz-Beyá, M.
- Vidriales, B.
- Raposo-Puglia, J. Ángel
- Arnan, M.
- Garrido, A.
- Balerdi, A.
- Cabello, A. Isabel
- Herrera-Puente, P.
- Serrano, J.
- Coll, R.
- Tormo, M.
- López-Marín, J.
- García-Ávila, S.
- Casado, M. Soledad
- Padilla, I.
- Rodríguez-Macías, G.
- Calbacho, M.
- Puchol, A.
- Hernández, A.
- Torres, M.
- Costilla, L.
- Colorado, M. Mercedes
- Martínez-Cuadrón, D.
- Esteve, J.
- Montesinos, P.
- on Google Scholar
- Vives, S.
- Quintela, D.
- Morgades, M.
- Cano-Ferri, I.
- Serrano, A.
- Acuña-Cruz, E.
- Cervera, M.
- Díaz-Beyá, M.
- Vidriales, B.
- Raposo-Puglia, J. Ángel
- Arnan, M.
- Garrido, A.
- Balerdi, A.
- Cabello, A. Isabel
- Herrera-Puente, P.
- Serrano, J.
- Coll, R.
- Tormo, M.
- López-Marín, J.
- García-Ávila, S.
- Casado, M. Soledad
- Padilla, I.
- Rodríguez-Macías, G.
- Calbacho, M.
- Puchol, A.
- Hernández, A.
- Torres, M.
- Costilla, L.
- Colorado, M. Mercedes
- Martínez-Cuadrón, D.
- Esteve, J.
- Montesinos, P.
- on PubMed
- Vives, S.
- Quintela, D.
- Morgades, M.
- Cano-Ferri, I.
- Serrano, A.
- Acuña-Cruz, E.
- Cervera, M.
- Díaz-Beyá, M.
- Vidriales, B.
- Raposo-Puglia, J. Ángel
- Arnan, M.
- Garrido, A.
- Balerdi, A.
- Cabello, A. Isabel
- Herrera-Puente, P.
- Serrano, J.
- Coll, R.
- Tormo, M.
- López-Marín, J.
- García-Ávila, S.
- Casado, M. Soledad
- Padilla, I.
- Rodríguez-Macías, G.
- Calbacho, M.
- Puchol, A.
- Hernández, A.
- Torres, M.
- Costilla, L.
- Colorado, M. Mercedes
- Martínez-Cuadrón, D.
- Esteve, J.
- Montesinos, P.
Need Help?
Order Article Reprints
Journal: Cancers, 2024
Volume: 16
Number: 4028
4028
Article:
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups
Authors:
by
Susana Vives, David Quintela, Mireia Morgades, Isabel Cano-Ferri, Alfons Serrano, Evelyn Acuña-Cruz, Marta Cervera, Marina Díaz-Beyá, Belén Vidriales, José Ángel Raposo-Puglia, Montserrat Arnan, Ana Garrido, Amaia Balerdi, Ana Isabel Cabello, Pilar Herrera-Puente, Josefina Serrano, Rosa Coll, Mar Tormo, Javier López-Marín, Sara García-Ávila, María Soledad Casado, Irene Padilla, Gabriela Rodríguez-Macías, María Calbacho, Ana Puchol, Agustín Hernández, Melissa Torres, Lissette Costilla, Maria Mercedes Colorado, David Martínez-Cuadrón, Jordi Esteve and Pau Montesinosadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2072-6694/16/23/4028
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Vives, S.; Quintela, D.; Morgades, M.; Cano-Ferri, I.; Serrano, A.; Acuña-Cruz, E.; Cervera, M.; Díaz-Beyá, M.; Vidriales, B.; Raposo-Puglia, J.Á.; et al. Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups. Cancers 2024, 16, 4028. https://doi.org/10.3390/cancers16234028
Vives S, Quintela D, Morgades M, Cano-Ferri I, Serrano A, Acuña-Cruz E, Cervera M, Díaz-Beyá M, Vidriales B, Raposo-Puglia JÁ, et al. Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups. Cancers. 2024; 16(23):4028. https://doi.org/10.3390/cancers16234028
Chicago/Turabian StyleVives, Susana, David Quintela, Mireia Morgades, Isabel Cano-Ferri, Alfons Serrano, Evelyn Acuña-Cruz, Marta Cervera, Marina Díaz-Beyá, Belén Vidriales, José Ángel Raposo-Puglia, and et al. 2024. "Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups" Cancers 16, no. 23: 4028. https://doi.org/10.3390/cancers16234028
APA StyleVives, S., Quintela, D., Morgades, M., Cano-Ferri, I., Serrano, A., Acuña-Cruz, E., Cervera, M., Díaz-Beyá, M., Vidriales, B., Raposo-Puglia, J. Á., Arnan, M., Garrido, A., Balerdi, A., Cabello, A. I., Herrera-Puente, P., Serrano, J., Coll, R., Tormo, M., López-Marín, J., ... Montesinos, P., on behalf of the CETLAM and PETHEMA Groups. (2024). Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups. Cancers, 16(23), 4028. https://doi.org/10.3390/cancers16234028
